BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10258416)

  • 21. FTC scrutiny of health care to be debated again..
    Prout DM
    Am Coll Physicians Obs; 1983 Mar; 3(3):8-9. PubMed ID: 10259352
    [No Abstract]   [Full Text] [Related]  

  • 22. "Free choice" as a restraint of trade in American health care delivery and insurance.
    Weller CD
    Spec Law Dig Health Care (Mon); 1986 Oct; 8(8):7-48. PubMed ID: 10280591
    [No Abstract]   [Full Text] [Related]  

  • 23. AMA's approval of FEC guidelines called restraint of trade by NAFEC.
    McCann J
    Emerg Dep News; 1983 Sep; 5(9):1, 12. PubMed ID: 10262215
    [No Abstract]   [Full Text] [Related]  

  • 24. Lawmakers concur with ACP on key aspects of debate.
    Am Coll Physicians Obs; 1983; 3(7):3. PubMed ID: 10263084
    [No Abstract]   [Full Text] [Related]  

  • 25. FTC, medical staffs reach agreements.
    Burda D
    Mod Healthc; 1988 Feb; 18(6):6. PubMed ID: 10285864
    [No Abstract]   [Full Text] [Related]  

  • 26. FTC rules on Michigan and Indiana antitrust cases.
    Rose A
    Health Law Vigil; 1983 Mar; 6(6):7-9. PubMed ID: 10278148
    [No Abstract]   [Full Text] [Related]  

  • 27. What competition can do to peer review.
    Holoweiko M
    Med Econ; 1985 Aug; 62(17):122-7, 131-9. PubMed ID: 10278339
    [No Abstract]   [Full Text] [Related]  

  • 28. Procompetitive standards OK, lawyer assures PPRC.
    Pollner F
    Med World News; 1989 Feb; 30(3):55. PubMed ID: 10294486
    [No Abstract]   [Full Text] [Related]  

  • 29. More competition, antitrust laws will not lead to better care.
    Klein J
    Psychiatr News; 1983 Jun; 18(11):1, 18. PubMed ID: 10263530
    [No Abstract]   [Full Text] [Related]  

  • 30. Federal antitrust laws and hospital concerns.
    Gramza M; Gire M
    Hosp Admin Curr; 1983; 27(3):13-8. PubMed ID: 10261676
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of Patrick v Burget.
    JCAH Perspect; 1986; 6(7-8):7-9. PubMed ID: 10289700
    [No Abstract]   [Full Text] [Related]  

  • 32. Steering clear of an antitrust charge.
    Trombetta WL
    Med Econ; 1986 Aug; 63(16):105-9, 112. PubMed ID: 10277667
    [No Abstract]   [Full Text] [Related]  

  • 33. Physician agreements to control medical prepayment plans: Federal Trade Commission. Adoption and publication of enforcement policy with respect to physician agreements to control medical prepayment plans.
    Fed Regist; 1981 Oct; 46(192):48982-92. PubMed ID: 10252959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Market definition, market power, and potential competition.
    Horowitz I
    Q Rev Econ Bus; 1982; 22(3):23-42. PubMed ID: 10257262
    [No Abstract]   [Full Text] [Related]  

  • 35. Historic Supreme Court decisions make clear that health care area is subject to antitrust scrutiny.
    Employee Benefit Plan Rev; 1982 Aug; 37(2):8-10. PubMed ID: 10259394
    [No Abstract]   [Full Text] [Related]  

  • 36. The year in review: significant health antitrust cases.
    Miles JJ
    Health Law Vigil; 1986 Jun; 9(11):3-7. PubMed ID: 10276706
    [No Abstract]   [Full Text] [Related]  

  • 37. Health care and antitrust.
    Heitler G
    Spec Law Dig Health Care (Mon); 1985 Jan; 6(11):5-35. PubMed ID: 10269565
    [No Abstract]   [Full Text] [Related]  

  • 38. Patient care not enough as defense for provider conduct.
    Hammaker MK
    Provider; 1987 Dec; 13(12):30-1, 40. PubMed ID: 10285093
    [No Abstract]   [Full Text] [Related]  

  • 39. Peer review of fees by physician groups: antitrust issues.
    Scott M
    Health Law Vigil; 1986 Jul; 9(14):5-8. PubMed ID: 10277308
    [No Abstract]   [Full Text] [Related]  

  • 40. General Electric may violate antitrust law with purchase of medical imaging business.
    Carter K
    Mod Healthc; 1986 Apr; 16(9):22. PubMed ID: 10276446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.